DOB Stats & Data

DOB is a potent, long-acting psychedelic amphetamine with active doses in the low milligram range; accurate milligram measurement or volumetric dosing is essential to reduce overdose risk. The onset is slow (often 1–3 hours), so redosing too early is a common error—waiting at least 3–4 hours before any redose materially lowers the chance of an overly strong experience. Severe peripheral vasoconstriction is a known toxicity at high doses; a published JAMA case linked DOB ingestion to diffuse arterial spasm requiring vasodilator treatment—seek urgent care if extremities become cold, numb, discolored, or intensely painful. Cardiovascular strain (tachycardia, hypertension) is common; those with vascular disease, Raynaud’s, hypertension, or cardiac risk should avoid DOB or take extra caution. Because DOB is sometimes found on blotters or mis-sold as LSD/other psychedelics, drug checking is strongly advised; when identity is uncertain, take a partial dose and wait several hours because some adulterants (including DOx) have much later onsets than LSD. The duration (often 18–30 hours) and residual stimulation can disrupt sleep into the next day; plan set/setting, obligations, and hydration/nutrition accordingly. Avoid combinations with other stimulants or vasoconstrictors (e.g., decongestants) to reduce additive blood pressure/vasospasm risks. Lithium coadministration with classical psychedelics has been repeatedly cautioned against in harm-reduction charts due to seizure risk; this combination should be avoided. MAOI co-use is high risk because DOB is serotonergic and stimulating; hypertensive crises or serotonin toxicity are possible even at typical doses. Alcohol may mask coming-up anxiety but can worsen dehydration and blood pressure; given the long duration, postponing alcohol until well after the peak (or avoiding it) improves safety. Given variance in street samples, start with a light dose even if prior experiences felt manageable; inter-batch potency and individual sensitivity can differ. If severe agitation, chest pain, or signs of limb ischemia occur, do not delay seeking medical care and disclose suspected DOB/‘DOx’ use so clinicians can monitor and manage vasospasm effectively.